New carbidopa/levodopa labels will state that seizures linked to vitamin B6 deficiency can ...

Ovid Therapeutics (OVID) shares jumped over 40% premarket as the biopharmaceutical company reported favorable safety and tolerability results for the 7 mg dose of its OV329 epilepsy drug, while ...

Azetukalner, a Kv7 potassium channel opener, reduced the frequency of focal onset seizures by a placebo-adjusted rate of 42.7 ...

Xenon Pharmaceuticals’ anti-seizure candidate has smashed a pivotal trial out of the park, lowering seizure rates by more ...

Prenatal exposure to safer antiseizure medications (ASMs) increased and valproate use decreased, but the use of newer medications with uncertain risks surged. Between 2013 and 2021, prenatal exposures ...

Future treatment resistance to focal epilepsy therapy was significantly more likely in individuals who reported suicidal ...

Ketogenic diet therapies, including the classic ketogenic diet, modified Atkins diet, and low glycaemic index treatment, have ...

A new paper, published in Science Translational Medicine, investigated whether levetiracetam, an anti-seizure medication, could form the basis for innovative drug treatments for Alzheimer’s disease.

Epileptic seizures alter sleep by prolonging the stage that's central to memory formation, potentially predisposing the brain to "remember" how to trigger subsequent seizures more easily, a small ...